Mucosal Vaccines Protect Mice from Viruses, Cancer
Mucosal Vaccines Protect Mice from Viruses, Cancer
Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.
Mucosal Vaccines Protect Mice from Viruses, Cancer
Mucosal Vaccines Protect Mice from Viruses, Cancer

Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.

Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.

vaccine
Scientific Breakthroughs with Cryogenic Electron Microscopy
Scientific Breakthroughs with Cryogenic Electron Microscopy
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Jun 10, 2021
Structures made via cryo-EM give researchers insights into SARS-CoV-2, HIV, neurological disorders, cancer, and more.
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
Ruth Williams | May 12, 2021
By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus and is known to occur with dengue and Zika.
Transforming Virology Research with Cryo-EM
Transforming Virology Research with Cryo-EM
The Scientist Creative Services Team | May 11, 2021
Explore what researchers can do with Cryo-EM
What Scientists Know About the B.1.617 Coronavirus Variant
What Scientists Know About the B.1.617 Coronavirus Variant
Shawna Williams | May 3, 2021
While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Catherine Offord | Apr 26, 2021
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso.
COVID-19 Vaccines Appear Safe During Pregnancy: Early Data
COVID-19 Vaccines Appear Safe During Pregnancy: Early Data
Christie Wilcox | Apr 22, 2021
Scientists at the US CDC report no red flags in a preliminary analysis of the safety of Pfizer/BioNTech’s and Moderna’s mRNA-based immunizations among expectant mothers.
Pharma, US Government Plan for COVID-19 Booster Shots
Pharma, US Government Plan for COVID-19 Booster Shots
Jef Akst | Apr 16, 2021
It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.
US Health Authorities Ask for Pause in J&J COVID-19 Vaccination
US Health Authorities Ask for Pause in J&J COVID-19 Vaccination
Kerry Grens | Apr 13, 2021
The FDA and CDC are investigating a handful of reports of blood clots that occurred several days after people received the one-and-done shot.
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
Shawna Williams | Apr 9, 2021
Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Catherine Offord | Apr 8, 2021
The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.
Bile and Potatoes, 1921
Bile and Potatoes, 1921
Jef Akst | Apr 1, 2021
One hundred years after its invention, BCG has stood the test of time as a vaccine against tuberculosis.
Pfizer Vaccine Induces Immune Structures Key to Lasting Immunity
Pfizer Vaccine Induces Immune Structures Key to Lasting Immunity
Katarina Zimmer | Mar 25, 2021
In the armpit lymph nodes of people who had received the mRNA vaccine against SARS-CoV-2, researchers found germinal centers needed to generate long-lived antibody-making cells.
AstraZeneca’s COVID-19 Shot Completely Prevented Severe Disease
AstraZeneca’s COVID-19 Shot Completely Prevented Severe Disease
Kerry Grens | Mar 22, 2021
The vaccine was 79 percent effective at blocking symptomatic infections, according to data from a Phase 3 trial in the US, Chile, and Peru. A US safety oversight board says the data might be incomplete.
Fast-Tracking COVID-19 Research
Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 17, 2021
Identifying molecular targets for SARS-CoV-2 therapeutics.
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
Variant Found in Brazil Could Evade Immunity from Past Infection
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.
US Authorizes a Third COVID-19 Vaccine
US Authorizes a Third COVID-19 Vaccine
Asher Jones | Mar 1, 2021
Johnson & Johnson’s one-shot immunization could reach people’s arms as early as March 2.
Democratized Discovery
Democratized Discovery
Bob Grant | Mar 1, 2021
In a triumph for science, COVID-19 statistics are finally trending favorably in the US. We must make sure the rest of the world is not left behind.